Chemicals - Specialty
Build Your Comparison
Side-by-side financial analysisStock Comparison
CMT vs CMI vs PCAR vs UFPT vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Agricultural - Machinery
Medical - Devices
Banks - Diversified
CMT vs CMI vs PCAR vs UFPT vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Industrial - Machinery | Agricultural - Machinery | Medical - Devices | Banks - Diversified |
| Market Cap | $227M | $91.13B | $62.37B | $1.81B | $896.00B |
| Revenue (TTM) | $271M | $33.89B | $27.24B | $603M | $280.33B |
| Net Income (TTM) | $10M | $2.67B | $2.48B | $68M | $57.05B |
| Gross Margin | 17.6% | 25.4% | 15.1% | 28.3% | 60.0% |
| Operating Margin | 4.4% | 11.2% | 9.7% | 15.3% | 25.9% |
| Forward P/E | 23.0x | 22.7x | 20.9x | 24.7x | 14.4x |
| Total Debt | $33M | $8.11B | $0.00 | $154M | $942.38B |
| Cash & Equiv. | $38M | $2.85B | $9.25B | $20M | $343.34B |
CMT vs CMI vs PCAR vs UFPT vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Core Molding Techno… (CMT) | 100 | 598.1 | +498.1% |
| Cummins Inc. (CMI) | 100 | 380.7 | +280.7% |
| PACCAR Inc (PCAR) | 100 | 237.5 | +137.5% |
| UFP Technologies, I… (UFPT) | 100 | 533.2 | +433.2% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CMT vs CMI vs PCAR vs UFPT vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CMT ranks third and is worth considering specifically for sleep-well-at-night and defensive.
- Lower volatility, beta 0.49, Low D/E 20.8%, current ratio 3.02x
- Beta 0.49, current ratio 3.02x
- Beta 0.49 vs CMI's 1.64, lower leverage
CMI is the clearest fit if your priority is momentum.
- +105.6% vs UFPT's -1.0%
PCAR is the clearest fit if your priority is income & stability.
- Dividend streak 5 yrs, beta 1.00, yield 3.6%
- 3.6% yield, 5-year raise streak, vs CMI's 1.2%, (2 stocks pay no dividend)
UFPT has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.
- Rev growth 19.5%, EPS growth 15.7%, 3Y rev CAGR 19.4%
- 10.2% 10Y total return vs CMI's 5.3%
- PEG 0.66 vs CMT's 4.08
- 19.5% revenue growth vs PCAR's -15.5%
JPM is the #2 pick in this set and the best alternative if value and quality is your priority.
- Lower P/E (14.4x vs 20.9x), PEG 0.81 vs 1.66
- 20.4% margin vs CMT's 3.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.5% revenue growth vs PCAR's -15.5% | |
| Value | Lower P/E (14.4x vs 20.9x), PEG 0.81 vs 1.66 | |
| Quality / Margins | 20.4% margin vs CMT's 3.5% | |
| Stability / Safety | Beta 0.49 vs CMI's 1.64, lower leverage | |
| Dividends | 3.6% yield, 5-year raise streak, vs CMI's 1.2%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +105.6% vs UFPT's -1.0% | |
| Efficiency (ROA) | 10.5% ROA vs JPM's 1.3%, ROIC 12.7% vs 4.5% |
CMT vs CMI vs PCAR vs UFPT vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CMT vs CMI vs PCAR vs UFPT vs JPM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CMI leads in 2 of 6 categories
JPM leads 1 • CMT leads 0 • PCAR leads 0 • UFPT leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 1034.7x CMT's $271M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to CMT's 3.5%. On growth, UFPT holds the edge at +3.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $271M | $33.9B | $27.2B | $603M | $280.3B |
| EBITDAEarnings before interest/tax | $21M | $4.6B | $3.3B | $116M | $81.4B |
| Net IncomeAfter-tax profit | $10M | $2.7B | $2.5B | $68M | $57.0B |
| Free Cash FlowCash after capex | -$15M | $2.7B | $3.4B | $79M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +17.6% | +25.4% | +15.1% | +28.3% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +4.4% | +11.2% | +9.7% | +15.3% | +25.9% |
| Net MarginNet income ÷ Revenue | +3.5% | +7.9% | +9.1% | +11.3% | +20.4% |
| FCF MarginFCF ÷ Revenue | -5.7% | +7.9% | +12.5% | +13.1% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.7% | +2.7% | -16.2% | +3.4% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -72.2% | -21.0% | +19.8% | +6.7% | +16.0% |
Valuation Metrics
Evenly matched — CMT and JPM each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, JPM trades at a 50% valuation discount to CMI's 32.2x P/E. Adjusting for growth (PEG ratio), UFPT offers better value at 0.71x vs CMT's 3.38x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $227M | $91.1B | $62.4B | $1.8B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $222M | $96.4B | $53.1B | $1.9B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 19.10x | 32.17x | 26.28x | 26.79x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 23.03x | 22.72x | 20.88x | 24.72x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | 3.38x | 2.85x | 2.08x | 0.71x | 0.90x |
| EV / EBITDAEnterprise value multiple | 8.34x | 19.40x | 14.02x | 16.81x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 0.83x | 2.71x | 2.19x | 3.01x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.35x | 6.82x | 3.24x | 4.33x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 118.29x | 38.19x | 20.59x | 22.94x | 8.88x |
Profitability & Efficiency
CMI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CMI delivers a 20.3% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $6 for CMT. CMT carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), CMI scores 7/9 vs PCAR's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.2% | +20.3% | +17.2% | +17.4% | +15.9% |
| ROA (TTM)Return on assets | +4.2% | +7.8% | +6.6% | +10.5% | +1.3% |
| ROICReturn on invested capital | +7.6% | +16.1% | +12.2% | +12.7% | +4.5% |
| ROCEReturn on capital employed | +7.8% | +17.3% | +8.9% | +16.1% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 3 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.21x | 0.61x | — | 0.36x | 2.60x |
| Net DebtTotal debt minus cash | -$5M | $5.3B | -$9.3B | $134M | $599.0B |
| Cash & Equiv.Liquid assets | $38M | $2.8B | $9.3B | $20M | $343.3B |
| Total DebtShort + long-term debt | $33M | $8.1B | $0 | $154M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 144.87x | 12.15x | 129.28x | 9.42x | 0.74x |
Total Returns (Dividends Reinvested)
CMI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in UFPT five years ago would be worth $40,725 today (with dividends reinvested), compared to $18,252 for CMT. Over the past 12 months, CMI leads with a +105.6% total return vs UFPT's -1.0%. The 3-year compound annual growth rate (CAGR) favors CMI at 43.7% vs CMT's 8.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +26.6% | +27.1% | +6.8% | +5.2% | -0.5% |
| 1-Year ReturnPast 12 months | +47.7% | +105.6% | +29.5% | -1.0% | +21.8% |
| 3-Year ReturnCumulative with dividends | +28.5% | +196.7% | +67.0% | +36.0% | +138.2% |
| 5-Year ReturnCumulative with dividends | +82.5% | +179.2% | +121.7% | +307.2% | +118.2% |
| 10-Year ReturnCumulative with dividends | +88.8% | +530.6% | +293.1% | +1018.2% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +8.7% | +43.7% | +18.6% | +10.8% | +33.6% |
Risk & Volatility
Evenly matched — CMT and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
CMT is the less volatile stock with a 0.49 beta — it tends to amplify market swings less than CMI's 1.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 95.1% from its 52-week high vs UFPT's 85.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.49x | 1.64x | 1.00x | 1.11x | 0.94x |
| 52-Week HighHighest price in past year | $28.69 | $718.08 | $131.88 | $274.93 | $337.25 |
| 52-Week LowLowest price in past year | $16.12 | $307.90 | $90.05 | $173.88 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +85.9% | +91.9% | +89.9% | +85.5% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 55.7 | 49.0 | 54.6 | 68.3 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 32K | 759K | 2.7M | 203K | 7.0M |
Analyst Outlook
Evenly matched — CMI and PCAR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CMT as "Buy", CMI as "Buy", PCAR as "Hold", UFPT as "Buy", JPM as "Buy". Consensus price targets imply 26.8% upside for UFPT (target: $298) vs -2.6% for CMT (target: $24). For income investors, PCAR offers the higher dividend yield at 3.63% vs CMI's 1.15%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $24.00 | $727.91 | $127.40 | $298.00 | $339.75 |
| # AnalystsCovering analysts | 2 | 51 | 45 | 2 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | +1.2% | +3.6% | — | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 20 | 5 | 0 | 15 |
| Dividend / ShareAnnual DPS | — | $7.61 | $4.30 | — | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.4% | 0.0% | +0.1% | 0.0% | +3.9% |
CMI leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). JPM leads in 1 (Income & Cash Flow). 3 tied.
CMT vs CMI vs PCAR vs UFPT vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CMT or CMI or PCAR or UFPT or JPM a better buy right now?
For growth investors, UFP Technologies, Inc.
(UFPT) is the stronger pick with 19. 5% revenue growth year-over-year, versus -15. 5% for PACCAR Inc (PCAR). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Core Molding Technologies, Inc. (CMT) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CMT or CMI or PCAR or UFPT or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 0x versus Cummins Inc. at 32. 2x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: UFP Technologies, Inc. wins at 0. 66x versus Core Molding Technologies, Inc. 's 4. 08x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CMT or CMI or PCAR or UFPT or JPM?
Over the past 5 years, UFP Technologies, Inc.
(UFPT) delivered a total return of +307. 2%, compared to +82. 5% for Core Molding Technologies, Inc. (CMT). Over 10 years, the gap is even starker: UFPT returned +1018% versus CMT's +88. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CMT or CMI or PCAR or UFPT or JPM?
By beta (market sensitivity over 5 years), Core Molding Technologies, Inc.
(CMT) is the lower-risk stock at 0. 49β versus Cummins Inc. 's 1. 64β — meaning CMI is approximately 238% more volatile than CMT relative to the S&P 500. On balance sheet safety, Core Molding Technologies, Inc. (CMT) carries a lower debt/equity ratio of 21% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — CMT or CMI or PCAR or UFPT or JPM?
By revenue growth (latest reported year), UFP Technologies, Inc.
(UFPT) is pulling ahead at 19. 5% versus -15. 5% for PACCAR Inc (PCAR). On earnings-per-share growth, the picture is similar: UFP Technologies, Inc. grew EPS 15. 7% year-over-year, compared to -42. 9% for PACCAR Inc. Over a 3-year CAGR, UFPT leads at 19. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CMT or CMI or PCAR or UFPT or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 4. 1% for Core Molding Technologies, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 5. 2% for CMT. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CMT or CMI or PCAR or UFPT or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, UFP Technologies, Inc. (UFPT) is the more undervalued stock at a PEG of 0. 66x versus Core Molding Technologies, Inc. 's 4. 08x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 4x forward P/E versus 24. 7x for UFP Technologies, Inc. — 10. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UFPT: 26. 8% to $298. 00.
08Which pays a better dividend — CMT or CMI or PCAR or UFPT or JPM?
In this comparison, PCAR (3.
6% yield), JPM (1. 9% yield), CMI (1. 2% yield) pay a dividend. CMT, UFPT do not pay a meaningful dividend and should not be held primarily for income.
09Is CMT or CMI or PCAR or UFPT or JPM better for a retirement portfolio?
For long-horizon retirement investors, JPMorgan Chase & Co.
(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 9% yield, +465. 8% 10Y return). Cummins Inc. (CMI) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JPM: +465. 8%, CMI: +530. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CMT and CMI and PCAR and UFPT and JPM?
These companies operate in different sectors (CMT (Basic Materials) and CMI (Industrials) and PCAR (Industrials) and UFPT (Healthcare) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CMT is a small-cap quality compounder stock; CMI is a mid-cap quality compounder stock; PCAR is a mid-cap income-oriented stock; UFPT is a small-cap high-growth stock; JPM is a large-cap deep-value stock. CMI, PCAR, JPM pay a dividend while CMT, UFPT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.